Thursday, 29 June 2017

Australia News

  • Painless vaccination unveiled!

    Australia |  Influencers | By Aishwarya Venkatesh | 0 Comment | 01 May, 2015

    Singapore: Though vaccination is considered the most important procedure for healthcare and disease management, it is not widely accepted by all sections of the society. Vaccination can be...Read more

  • STA to distribute novel cancer drug in Australia, NZ

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2015

    Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA),  has partnered with European pharmaceutical company PharmaMar to market and distribute the novel ...Read more

  • Aussie firm likely to get orphan status for its new drug

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 28 Apr, 2015

    Singapore: Australia based Prana Biotechnology has recieved positive opinion from European Medicines Agency's Committee for Orphan Medicinal Products (COMP) for the designation of its drug ...Read more

  • Phylogica assess financial, strategic opportunities

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 10 Apr, 2013

    Singapore: Phylogica has engaged Griffin Securities, a specialty investment bank located in New York City, to conduct a formal process for evaluating strategic opportunities available to th...Read more

  • Soon, a single flu shot may offer universal immunity!

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 19 May, 2015

    Singapore: A single vaccine that immunizes against all types of influenza may soon be a reality, after a team of scientists from Australia and China have discovered how the body's immunity ...Read more

  • Sale of wound care devices spurs in Asia-Pacific: Frost & Sullivan analysis report

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2013

    Singapore: Advanced wound care and modern wound closure products are gaining an edge over traditional wound dressings in Asia Pacific as lower bed capacity in hospitals and the trend toward...Read more

  • TGA approves Hospira's biosimilar Inflectra

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2015

    Singapore: US drug giant Hospira recently announced that the biosimilar Inflectra (infliximab) has been registered as a therapy in Australia. Inflectra is an artificial compound that is bio...Read more

  • Sun Pharma to buy GSK's Opiates business in Australia

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 03 Mar, 2015

    Singapore: GlaxoSmithKline (GSK) and Sun Pharmaceutical announced that their respective wholly owned subsidiaries have reached an agreement related to GSK's Opiates business in Australia. ...Read more

  • Novogen's drug shows positive result for brain cancer

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2015

    Singapore: Australian biotechnology company, Novogen's lead candidate product, TRXE-009, has shown a positive result in treating adult and pediatric brain cancer. The study looked at the a...Read more

  • Amneal pharma to acquire Actavis Australia's generic business

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 02 Apr, 2015

    Singapore: US-based Amneal pharmaceuticals announced the acquisition of Actavis pharmaceuticals' generic business in Australia. The company has inked a binding letter of intent to acquire t...Read more

  • ANI pharma, IDT Australia to commercialize US generic drugs

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 18 Aug, 2015

    Singapore: ANI Pharmaceuticals, a global specialty pharmaceutical company recently announced collaboration with IDT Australia a global generic manufacturer, to commercialize up to 18 previo...Read more

  • Novartis to acquire Spinifex Pharmaceuticals

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 30 Jun, 2015

    Singapore: Novartis has announced that it has entered into an agreement to acquire Spinifex Pharmaceuticals, a US and Australia-based, privately held development stage company, focused on d...Read more

  • Charting Success year-on-year

    Australia |  Analysis | By BioSpectrum Bureau | 0 Comment | 23 Jun, 2015

    Singapore:  CSL, AustraliaChairman: Professor John ShineRevenue: $6407.8 mnBusiness: Developer and manufacturer of vaccines and plasma protein biotherapies Starting the year on a positiv...Read more

  • Phosphagenics achieves biggest milestone yet

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2013

    Singapore: Australian drug delivery technology company, Phosphagenics has achieved succes in its multi-dose oxymorphone patch phase I trial in 12 subjects. The phase I trial was conducted a...Read more

  • Market cap in APAC touches $200 bn

    Australia |  Analysis | By Narayan Kulkarni | 0 Comment | 15 Jun, 2012

    About 500 bioscience companies comprising pharmaceutical, biotechnology and medical technology companies listed on different stock exchanges in Asia Pacific (APAC) region and in American st...Read more

  • Aussie firm trials combination therapy for melanoma

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 29 Sep, 2015

    Singapore: Australia based Viralytics has initiated a clinical trial to assess its oncolytic virus, Cavatak, in combination with the checkpoint inhibitor Keytruda (pembrolizumab) in late-st...Read more

  • Aussie chemotherapy drug gets orphan designation

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2015

    Singappore: US Food and Drug Administration (FDA) has granted orphan drug designation to chemotherapy drug candidate Cantrixil for ovarian cancer developed by CanTx, a subsidiary joint vent...Read more

  • Scientists find microRNA linked to prostate cancer

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2012

    Singapore: 'Non-coding' genes known as microRNAs play a big role in cancer through their mechanical regulation of other genes. In a three-year study, researchers at Garvan Institute of Medi...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls